vTv Therapeutics Inc. (VTVT)

Analysts 2
Positive
100%
Median target $24 (330% upside)


    • 03/29/17
      Piper Jaffray
      overweight
      $24
      "This morning vTv announced presentation on its Phase II Type 2 diabetes data from oral GKa..."
      View details
    • 11/07/16
      H.C. Wainwright
      buy
    • 12/17/15
      Janney Montgomery Scott
      buy
      $21
    • 09/04/15
      Canaccord Genuity
      buy
      $15
      "The lead horse is azeliregon an Alzheimer's disease drug in Phase 3 with a novel mechanism of..."
      View details
    • 08/24/15
      Stifel Nicolaus
      buy
      $17
      "vTv Therapeutics at its core is a sophisticated chemistry company like Vertex and Array before..."
      View details
    • 100% positive
      $24 Median

    Best rated stocks last 7 days

    more

    Most rated stocks last 72 hrs

    more